Karyopharm Therapeutics Inc. (KPTI) Executive Compensation
Karyopharm Therapeutics Inc. (KPTI) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KPTI
CIK: 1503802
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerVictoria Forward
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-19 | 2026-10-16 | 4 | 0001193125-26-425227 | View SEC Doc Filr Page |
| 8-K | 2026-10-14 | 2026-10-13 | 8-K | 0001193125-26-421025 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-08 | — | SCHEDULE 13G/A Filing | 0001636587-26-000086 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001193125-26-412209 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-25 | — | SCHEDULE 13G/A Filing | 0001636587-26-000084 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-25 | — | SCHEDULE 13G/A Filing | 0001636587-26-000083 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-17 | 8-K | 0001193125-26-395517 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-10 | 8-K | 0001193125-26-388621 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-04 | — | SCHEDULE 13G Filing | 0001104659-26-105556 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | 4 | 0001193125-26-380404 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-31 | 8-K | 0001193125-26-375495 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000925 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001831942-26-000037 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-347906 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-347897 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000919574-26-004964 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-11 | — | SCHEDULE 13G/A Filing | 0000886982-26-000401 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-30 | 8-K | 0001193125-26-326995 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | 4 | 0001193125-26-326290 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-28 | — | SCHEDULE 13G Filing | 0002012383-26-002546 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-13 | 8-K | 0001193125-26-307964 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-05 | — | SCHEDULE 13G/A Filing | 0001897612-26-000511 | View SEC Doc Filr Page |
| 8-K | 2026-05-28 | 2026-05-21 | 8-K | 0001503802-26-000027 | View SEC Doc Filr Page |
| S-8 | 2026-05-27 | — | S-8 | 0001193125-26-242089 | View SEC Doc Filr Page |
| S-8 | 2026-05-27 | — | S-8 | 0001193125-26-242083 | View SEC Doc Filr Page |